| Page 989 | Kisaco Research
 

Ryoma Hara

Principal Scientist, Chemistry
FIMECS

Ryoma Hara

Principal Scientist, Chemistry
FIMECS

Ryoma Hara

Principal Scientist, Chemistry
FIMECS
 

Giovanni Spagnolli

Co-founder, Chief Technology Officer
Sibylla Biotech

Giovanni Spagnolli

Co-founder, Chief Technology Officer
Sibylla Biotech

Giovanni Spagnolli

Co-founder, Chief Technology Officer
Sibylla Biotech
 

Giovanni Spagnolli

Co-founder, Chief Technology Officer
Sibylla Biotech

Giovanni Spagnolli

Co-founder, Chief Technology Officer
Sibylla Biotech

Giovanni Spagnolli

Co-founder, Chief Technology Officer
Sibylla Biotech
 

Alzbeta Tuerkova

Head of Computer-Aided Drug Design
Celeris Therapeutics

Alzbeta Tuerkova

Head of Computer-Aided Drug Design
Celeris Therapeutics

Alzbeta Tuerkova

Head of Computer-Aided Drug Design
Celeris Therapeutics
 

Alzbeta Tuerkova

Head of Computer-Aided Drug Design
Celeris Therapeutics

Alzbeta Tuerkova

Head of Computer-Aided Drug Design
Celeris Therapeutics

Alzbeta Tuerkova

Head of Computer-Aided Drug Design
Celeris Therapeutics
 

Mary Matyskiela

VP, Molecular Sciences and Lead Discovery
Neomorph

Mary Matyskiela

VP, Molecular Sciences and Lead Discovery
Neomorph

Mary Matyskiela

VP, Molecular Sciences and Lead Discovery
Neomorph
 

Kevin Moreau

Director, Safety Innovation and PROTAC Science Lead
AstraZeneca

Kevin Moreau

Director, Safety Innovation and PROTAC Science Lead
AstraZeneca

Kevin Moreau

Director, Safety Innovation and PROTAC Science Lead
AstraZeneca
 

Kevin Moreau

Director, Safety Innovation and PROTAC Science Lead
AstraZeneca

Kevin Moreau

Director, Safety Innovation and PROTAC Science Lead
AstraZeneca

Kevin Moreau

Director, Safety Innovation and PROTAC Science Lead
AstraZeneca
 

Luc Brunsveld

Co-Founder
Ambagon Therapeutics

Luc Brunsveld

Co-Founder
Ambagon Therapeutics

Luc Brunsveld

Co-Founder
Ambagon Therapeutics